237 related articles for article (PubMed ID: 30215334)
1. Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?
Solanki A; Bhatt LK; Johnston TP; Prabhavalkar KS
Curr Protein Pept Sci; 2019; 20(4):324-333. PubMed ID: 30215334
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy.
Kowluru RA; Mishra M
Prog Mol Biol Transl Sci; 2017; 148():67-85. PubMed ID: 28662829
[TBL] [Abstract][Full Text] [Related]
3. MMP targeting in the battle for vision: Recent developments and future prospects in the treatment of diabetic retinopathy.
Drankowska J; Kos M; Kościuk A; Marzęda P; Boguszewska-Czubara A; Tylus M; Święch-Zubilewicz A
Life Sci; 2019 Jul; 229():149-156. PubMed ID: 31100326
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.
Kowluru RA; Kanwar M
Free Radic Biol Med; 2009 Jun; 46(12):1677-85. PubMed ID: 19345729
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.
Kowluru RA; Zhong Q; Santos JM
Expert Opin Investig Drugs; 2012 Jun; 21(6):797-805. PubMed ID: 22519597
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.
Kuhad A; Singh P; Chopra K
Expert Opin Ther Targets; 2015 Feb; 19(2):177-85. PubMed ID: 25243524
[TBL] [Abstract][Full Text] [Related]
7. Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy.
Mohammad G; Siddiquei MM
J Ocul Biol Dis Infor; 2012 Mar; 5(1):1-8. PubMed ID: 23833698
[TBL] [Abstract][Full Text] [Related]
8. Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.
Santos JM; Tewari S; Lin JY; Kowluru RA
Biochem Biophys Res Commun; 2013 Sep; 438(4):760-4. PubMed ID: 23891690
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy.
Salzmann J; Limb GA; Khaw PT; Gregor ZJ; Webster L; Chignell AH; Charteris DG
Br J Ophthalmol; 2000 Oct; 84(10):1091-6. PubMed ID: 11004090
[TBL] [Abstract][Full Text] [Related]
10. Loss of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) in the Diabetic Retina: Role of Matrix Metalloproteinases.
Eshaq RS; Harris NR
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):748-760. PubMed ID: 30793207
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
Yang R; Liu H; Williams I; Chaqour B
Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
[TBL] [Abstract][Full Text] [Related]
12. [Structure Activity Relationship Study of Polymethoxylated Flavones Targeted Retinal Müller Cells for Prevention of Retinal Diseases].
Miyata Y
Yakugaku Zasshi; 2021; 141(1):41-45. PubMed ID: 33390446
[TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinases: A challenging paradigm of cancer management.
Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
[TBL] [Abstract][Full Text] [Related]
14. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].
Naduk-Kik J; Hrabec E
Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849
[TBL] [Abstract][Full Text] [Related]
15. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
16. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
Gargiulo S; Gamba P; Poli G; Leonarduzzi G
Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
[TBL] [Abstract][Full Text] [Related]
17. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
Rashid ZA; Bardaweel SK
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibition in atherosclerosis and stroke.
Roycik MD; Myers JS; Newcomer RG; Sang QX
Curr Mol Med; 2013 Sep; 13(8):1299-313. PubMed ID: 23865428
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
